Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124708012 | 12470801 | 2 | F | 201301 | 20160620 | 20160616 | 20160701 | EXP | US-ACORDA-ACO_122037_2016 | ACORDA | 55.73 | YR | F | Y | 106.58000 | KG | 20160701 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124708012 | 12470801 | 1 | PS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, BID | U | 0000078848 | 22250 | 10 | MG | TABLET | BID | ||||
| 124708012 | 12470801 | 2 | SS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, BID | U | 22250 | 10 | MG | TABLET | BID | |||||
| 124708012 | 12470801 | 3 | C | COPAXONE | GLATIRAMER ACETATE | 1 | Subcutaneous | 20 MG, QD | U | 0 | 20 | MG | QD | ||||||
| 124708012 | 12470801 | 4 | C | LYRICA | PREGABALIN | 1 | Oral | 150 MG, QD | U | 0 | 150 | MG | QD | ||||||
| 124708012 | 12470801 | 5 | C | EFFEXOR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 150 MG, QD | U | 0 | 150 | MG | QD | ||||||
| 124708012 | 12470801 | 6 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 1000 MG, BID | U | 0 | 1000 | MG | BID | ||||||
| 124708012 | 12470801 | 7 | C | SINEMET | CARBIDOPALEVODOPA | 1 | Oral | 25/100 UNK, HS | U | 0 | QD | ||||||||
| 124708012 | 12470801 | 8 | C | Amantadine | AMANTADINE | 1 | Oral | 100 MG, BID | U | 0 | 100 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124708012 | 12470801 | 1 | Gait disturbance |
| 124708012 | 12470801 | 2 | Multiple sclerosis |
| 124708012 | 12470801 | 3 | Multiple sclerosis |
| 124708012 | 12470801 | 4 | Product used for unknown indication |
| 124708012 | 12470801 | 5 | Product used for unknown indication |
| 124708012 | 12470801 | 6 | Diabetes mellitus |
| 124708012 | 12470801 | 7 | Restless legs syndrome |
| 124708012 | 12470801 | 8 | Multiple sclerosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124708012 | 12470801 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124708012 | 12470801 | Drug ineffective | |
| 124708012 | 12470801 | Fall | |
| 124708012 | 12470801 | Gait disturbance | |
| 124708012 | 12470801 | Multiple sclerosis relapse | |
| 124708012 | 12470801 | Therapy cessation | |
| 124708012 | 12470801 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124708012 | 12470801 | 1 | 20130122 | 0 | ||
| 124708012 | 12470801 | 2 | 20130330 | 0 |